Tri-State Memorial Hospital Inc Dialysis Unit is a medicare approved dialysis facility center in Clarkston, Washington and it has 12 dialysis stations. It is located in Asotin county at 1221 Highland Ave, Clarkston, WA, 99403. You can reach out to the office of Tri-State Memorial Hospital Inc Dialysis Unit at (509) 758-4656. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Tri-State Memorial Hospital Inc Dialysis Unit has the following ownership type - Non-Profit. It was first certified by medicare in March, 1988. The medicare id for this facility is 500057 and it accepts patients under medicare ESRD program.
| Name | Tri-State Memorial Hospital Inc Dialysis Unit |
|---|---|
| Location | 1221 Highland Ave, Clarkston, Washington |
| No. of Dialysis Stations | 12 |
| Medicare ID | 500057 |
| Managed By | Independent |
| Ownership Type | Non-Profit |
| Late Shifts | Yes |
| 1221 Highland Ave, Clarkston, Washington, 99403 | |
| (509) 758-4656 | |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago
| NPI Number | 1124186804 |
| Doing Business As | Tri State Memorial Hospital |
| Address | 1221 Highland Ave Clarkston, Washington, 99403 |
| Phone Number | (509) 758-5511 |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 91% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 8% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 1% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 86% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 14% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 0% | 14% |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 74% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 20% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 6% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 79% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 21% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 0% | 12% |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 86% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 14% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 93% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 7% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 0% | 12% |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago
| Dialysis patients with Hemoglobin data | 25 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 24 |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 54 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 464 |
| Percentage of adult patients getting regular hemodialysis at the center | 96 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago
| Adult patients getting regular peritoneal dialysis at the center | 5 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 43 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Tri-State Memorial Hospital Inc Dialysis Unit with elevated calcium levels.
| Patients with hypercalcemia | 64 |
| Hypercalcemia patient months | 594 |
| Patients with Serumphosphor | 64 |
| Patients with Serumphosphor less than 3.5 mg/dL | 4 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 19 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 27 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 32 |
| Patients with Serumphosphor greater than 7 mg/dL | 18 |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 61 |
| Patient months included in arterial venous fistula and catheter summaries | 482 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 72 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 20 |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 64 |
| Hospitalization Rate in facility | 118.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 234.8 |
| Hospitalization Rate: Lower Confidence Limit | 62.4 |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago
The rate of readmission show you whether patients who were being treated regularly at Tri-State Memorial Hospital Inc Dialysis Unit were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 14.4 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 30.1 |
| Readmission Rate: Lower Confidence Limit | 5 |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Tri-State Memorial Hospital Inc Dialysis Unit get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.88 (As Expected) |
| SIR: Upper Confidence Limit | 3.34 |
| SIR: Lower Confidence Limit | .95 |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Tri-State Memorial Hospital Inc Dialysis Unit's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 45 |
| Transfusion Rate in facility | 13.3 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 78.1 |
| Transfusion Rate: Lower Confidence Limit | 2.8 |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago
The rate of mortality show you whether patients who were being treated regularly at Tri-State Memorial Hospital Inc Dialysis Unit lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 384 |
| Mortality Rate in facility | 20.4 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 26.2 |
| Mortality Rate: Lower Confidence Limit | 15.5 |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago
Tri-State Memorial Hospital Inc Dialysis Unit Location: 1221 Highland Ave, Clarkston, Washington, 99403 Phone: (509) 758-4656 |
News Archive
Penn Pharma Americas announced today that Sagefrog Marketing Group, LLC, a full service marketing, interactive and public relations company, has been awarded a contract for Agency of Record for both marketing and public relations.
Biomedical engineer Muhammet Uzuntarla from Bulent Ecevit University, Turkey, and his colleagues present a biologically accurate model of the underlying noise which is present in the nervous system.
There are no differences in growth, body composition or breast milk intake among HIV-negative infants, whether born to HIV-positive or HIV-negative mothers, an IAEA-supported research project in Kenya has found.
Researchers in Canada have detected a novel oncolytic viral therapy against prostate cancer with use of a virus called the reovirus, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.
Shrink Nanotechnologies, Inc. an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering the StemDisc450, a high-yield, low cost, patent-pending cell culturing biomedical research tool.
› Verified 9 days ago